| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ... Hepatology 65 (5), 1557-1565, 2017 | 1803 | 2017 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1135 | 2019 |
| Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ... Gastroenterology 158 (6), 1611-1625. e12, 2020 | 818 | 2020 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 372 | 2020 |
| Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy G Sebastiani, A Alberti World journal of gastroenterology: WJG 12 (23), 3682, 2006 | 370 | 2006 |
| Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C G Sebastiani, A Vario, M Guido, F Noventa, M Plebani, R Pistis, A Ferrari, ... Journal of hepatology 44 (4), 686-693, 2006 | 359 | 2006 |
| Chronic hepatitis C and liver fibrosis G Sebastiani, K Gkouvatsos, K Pantopoulos World journal of gastroenterology: WJG 20 (32), 11033, 2014 | 326 | 2014 |
| Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C L Castéra, G Sebastiani, B Le Bail, V de Lédinghen, P Couzigou, A Alberti Journal of hepatology 52 (2), 191-198, 2010 | 301 | 2010 |
| Limitations of non-invasive tests for assessment of liver fibrosis K Patel, G Sebastiani JHEP Reports 2 (2), 100067, 2020 | 248 | 2020 |
| SAFE biopsy: a validated method for large‐scale staging of liver fibrosis in chronic hepatitis C G Sebastiani, P Halfon, L Castera, S Pol, DL Thomas, A Mangia, ... Hepatology 49 (6), 1821-1827, 2009 | 239 | 2009 |
| Liver fibrosis: Review of current imaging and MRI quantification techniques L Petitclerc, G Sebastiani, G Gilbert, G Cloutier, A Tang Journal of Magnetic Resonance Imaging 45 (5), 1276-1295, 2017 | 235 | 2017 |
| Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B G Sebastiani, A Vario, M Guido, A Alberti World journal of gastroenterology: WJG 13 (4), 525, 2007 | 197 | 2007 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 193 | 2022 |
| Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study G Sebastiani, D Tempesta, G Fattovich, L Castera, P Halfon, M Bourliere, ... Journal of hepatology 53 (4), 630-638, 2010 | 189 | 2010 |
| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ... HIV medicine 21 (10), 617-624, 2020 | 172 | 2020 |
| The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases G Sebastiani, L Castera, P Halfon, S Pol, A Mangia, V Di Marco, M Pirisi, ... Alimentary pharmacology & therapeutics 34 (10), 1202-1216, 2011 | 151 | 2011 |
| Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis S Petta, G Sebastiani, E Bugianesi, M Viganň, VWS Wong, A Berzigotti, ... Journal of hepatology 69 (4), 878-885, 2018 | 141 | 2018 |
| A seven‐gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C M Marcolongo, B Young, F Dal Pero, G Fattovich, L Peraro, M Guido, ... Hepatology 50 (4), 1038-1044, 2009 | 132 | 2009 |
| Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease T Bessissow, NH Le, K Rollet, W Afif, A Bitton, G Sebastiani Inflammatory bowel diseases 22 (8), 1937-1944, 2016 | 131 | 2016 |
| Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver … S Petta, G Sebastiani, M Viganň, J Ampuero, VWS Wong, J Boursier, ... Clinical gastroenterology and hepatology 19 (4), 806-815. e5, 2021 | 125 | 2021 |
ALFREDO ALBERTIUniversity of PadovaVerified email at unipd.it
